SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-08 |
| Reported value | $47,529,385 |
| Positions | 27 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| NUVALENT INC | NUVL | COM | $3,192,475 | 25,850 |
| JANUS HENDERSON GROUP PLC | JHG | ORD SHS | $3,036,789 | 58,456 |
| BIO-TECHNE CORP | TECH | COM | $2,970,833 | 42,050 |
| NORFOLK SOUTHN CORP | NSC | COM | $2,684,082 | 8,532 |
| SELECT MED HLDGS CORP | SEM | COM | $2,680,035 | 162,328 |
| TALKSPACE INC | TALK | COM | $2,488,044 | 478,470 |
| APOGEE THERAPEUTICS INC | APGE | COM | $2,418,606 | 18,222 |
| CATALYST PHARMACEUTICALS INC | CPRX | COM | $2,397,669 | 76,286 |
| UNIFIRST CORP MASS | UNF | COM | $2,322,488 | 8,782 |
| SILICON LABORATORIES INC | SLAB | COM | $2,301,437 | 10,530 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.